| Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway J Polivka Jr, F Janku Pharmacology & therapeutics 142 (2), 164-175, 2014 | 885 | 2014 |
| Advances in experimental targeted therapy and immunotherapy for patients with glioblastoma multiforme J Polivka, L Holubec, T Kubikova, V Priban, O Hes, K Pivovarcikova, ... Anticancer research 37 (1), 21-33, 2017 | 159 | 2017 |
| Length of occlusion predicts recanalization and outcome after intravenous thrombolysis in middle cerebral artery stroke V Rohan, J Baxa, R Tupy, L Cerna, P Sevcik, M Friesl, J Polivka Jr, ... Stroke 45 (7), 2010-2017, 2014 | 101 | 2014 |
| “Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset?“Flammer Syndrome” relevance to address the question R Bubnov, J Polivka Jr, P Zubor, K Konieczka, O Golubnitschaja EPMA Journal 8 (2), 141-157, 2017 | 100* | 2017 |
| Caution,“normal” BMI: health risks associated with potentially masked individual underweight—EPMA Position Paper 2021 O Golubnitschaja, A Liskova, L Koklesova, M Samec, K Biringer, ... EPMA Journal 12 (3), 243-264, 2021 | 96 | 2021 |
| New molecularly targeted therapies for glioblastoma multiforme J POLIVKA, V ROHAN, O TOPOLCAN, J FERDA Anticancer research 32 (7), 2935-2946, 2012 | 85 | 2012 |
| Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach J Polivka, J Polivka, M Pesta, V Rohan, L Celedova, S Mahajani, ... EPMA Journal 10, 81-99, 2019 | 70 | 2019 |
| Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation M Kropp, O Golubnitschaja, A Mazurakova, L Koklesova, N Sargheini, ... Epma Journal 14 (1), 21-42, 2023 | 67 | 2023 |
| “Dry mouth” and “Flammer” syndromes—neglected risks in adolescents and new concepts by predictive, preventive and personalised approach A Kunin, J Polivka, N Moiseeva, O Golubnitschaja EPMA Journal 9, 307-317, 2018 | 66 | 2018 |
| Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach? P Zubor, A Gondova, J Polivka Jr, P Kasajova, K Konieczka, J Danko, ... EPMA Journal 8 (2), 129-140, 2017 | 57 | 2017 |
| Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet? J Polivka Jr, M Pesta, F Janku Expert review of molecular diagnostics 15 (12), 1631-1644, 2015 | 56 | 2015 |
| Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine J Polivka, I Altun, O Golubnitschaja Epma Journal 9, 1-13, 2018 | 55 | 2018 |
| The role of cetuximab in the induction of anticancer immune response in colorectal cancer treatment L Holubec, J Polivka, M Safanda, M Karas, V Liska Anticancer research 36 (9), 4421-4426, 2016 | 54 | 2016 |
| Current status of biomarker research in neurology J Polivka, J Polivka, K Krakorova, M Peterka, O Topolcan EPMA journal 7, 1-13, 2016 | 50 | 2016 |
| Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon? J Polivka, M Kralickova, J Polivka, C Kaiser, W Kuhn, O Golubnitschaja EPMA Journal 8, 119-127, 2017 | 47 | 2017 |
| Isocitrate dehydrogenase-1 mutations as prognostic biomarker in glioblastoma multiforme patients in West Bohemia J Polivka, V Rohan, M Pesta, T Repik, P Pitule, O Topolcan BioMed research international 2014, 2014 | 45 | 2014 |
| Vaginal dryness: individualised patient profiles, risks and mitigating measures V Goncharenko, R Bubnov, J Polivka, P Zubor, K Biringer, T Bielik, ... Epma Journal 10, 73-79, 2019 | 43 | 2019 |
| Plasma microRNA levels combined with CEA and CA19-9 in the follow-up of colorectal cancer patients M Pesta, R Kucera, O Topolcan, M Karlikova, K Houfkova, J Polivka, ... Cancers 11 (6), 864, 2019 | 39 | 2019 |
| Flammer syndrome: from phenotype to associated pathologies, prediction, prevention and personalisation O Golubnitschaja Springer, 2019 | 37 | 2019 |
| Postmenopausal breast cancer: European challenge and innovative concepts I Smokovski, M Risteski, J Polivka Jr, P Zubor, K Konieczka, V Costigliola, ... EPMA Journal 8 (2), 159-169, 2017 | 36 | 2017 |
